Simple Summary Diabetes mellitus is a common disease in patients with cancer. It is a risk
factor for certain cancers such as pancreatic, liver, colon, breast, and endometrial cancer …

Metformin is a standard clinical drug used to treat type 2 diabetes mellitus (T2DM) and
polycystic ovary syndrome. Recently, epidemiological studies and meta‑analyses have …

Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …

ABSTRACT The American Association of Clinical Endocrinologists/American College of
Endocrinology Medical Guidelines for Clinical Practice are systematically developed …

Background Increasing evidence suggests that diabetes mellitus (DM) is associated with
increased cancer incidence and mortality. Several mechanisms involved in diabetes, such …

BACKGROUND: Diabetes mellitus is associated with an increased incidence of colorectal
cancer, but the impact of diabetes mellitus on colorectal cancer prognosis is not clear …

In this paper we address methodological aspects of aetiological importance in the link
between diabetes and mortality in patients with cancer. We identified nine key points on the …

Background There are conflicting results as to the association between pre-existing diabetes
and the risk of mortality in patients with prostate cancer. The purpose of this study is to …

Introduction Diabetes mellitus (DM) is an important risk factor for endocrine cancers;
however, the association with thyroid cancer is not clear. We performed a systematic review …

The purpose of this study was to investigate the clinical, pathological, and prognostic
characteristics of breast cancer patients with diabetes. In total, the study included 1,013 …